dipyridamole has been researched along with Trypanosomiasis, African in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Trypanosomiasis, African: A disease endemic among people and animals in Central Africa. It is caused by various species of trypanosomes, particularly T. gambiense and T. rhodesiense. Its second host is the TSETSE FLY. Involvement of the central nervous system produces African sleeping sickness. Nagana is a rapidly fatal trypanosomiasis of horses and other animals.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bland, ND | 1 |
| Wang, C | 1 |
| Tallman, C | 1 |
| Gustafson, AE | 1 |
| Wang, Z | 1 |
| Ashton, TD | 1 |
| Ochiana, SO | 1 |
| McAllister, G | 1 |
| Cotter, K | 1 |
| Fang, AP | 1 |
| Gechijian, L | 1 |
| Garceau, N | 1 |
| Gangurde, R | 1 |
| Ortenberg, R | 1 |
| Ondrechen, MJ | 1 |
| Campbell, RK | 1 |
| Pollastri, MP | 1 |
1 other study available for dipyridamole and Trypanosomiasis, African
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecu | 2011 |